+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tissue Engineering Market- Growth, Trends, and Forecasts (2020 - 2025)

  • PDF Icon


  • 113 Pages
  • June 2020
  • Region: Global
  • Mordor Intelligence
  • ID: 4896021
UP TO OFF until Mar 31st 2024
The tissue engineering market will show rapid growth due to the increasing incidences of chronic diseases, road accidents, and trauma injuries, technological advancements in 3d tissue engineering, and ongoing research for tissue regeneration.

The rising chronic diseases, road accidents, and trauma injuries are found to be contributing to the growth in the development of tissue engineering solutions. There is increasing number of people in need of bone implants that are on the rise owing to the increasing cases of chronic diseases, trauma cases, and growing average life span.

Furthermore, there is also a demand for relatively cheap and available skin-replacement products that have encouraged many research groups worldwide to focus on creating biomaterials for skin substitution. The engineered tissues not only closes wounds but also stimulates the regeneration of the dermis and would provide a significant benefit in human wound healing. Moreover, the increasing prevalence of chronic diseases alongside road accidents, injuries, and trauma cases escalates the market on the global platform.

Key Market Trends

Cardiology & Vascular Segment is Expected to Show the Fastest Growth During the Forecast Period

Cardiology and the vascular segment are likely to grow at the fastest rate in the coming years, due to the rapidly rising incidence rate of cardiovascular diseases and lifestyle changes. According to the American College of Cardiology, cardiovascular disease (CVD) accounted for 800,000 deaths in the United States in 2017 alone. Among Americans, an average of one person dies from cardiovascular disease, every 40 seconds.

There is a rising number of replacements as well as reconstructive surgeries that have favored the industry growth. Despite various technological advancements in this field, cardiovascular disorders are one of the leading causes of death globally. There are advancements in tissue engineering also that are likely to boost the market growth.

Asia-pacific is Expected to Record a High Growth During the Forecast Period

Asia Pacific regional segment is expected to witness the fastest growth over the forecast period, due to the increasing demand for regenerative medicines. There is also growth in medical tourism that helps to accelerate market growth. Moreover, the growing burden and changing lifestyle is also projected to significantly impact market growth over the forecast period. In Asia, more than 1 in 5 cardiovascular diseases, such as heart attack and stroke, results from smoking. The Heart Foundation states that CVD is a major cause of death in Australia, with 43,477 deaths attributed to CVD in 2017.

Furthermore, the market is also increasing due to the rising biomaterial-based research, increasing demand for plastic surgeries, a growing number of cancer incidences and the increasing prevalence of cardiovascular diseases.

Competitive Landscape

There has been a presence of a considerable number of companies that are significantly contributing to market growth. These companies' new product developments, mergers, and acquisitions are some of the strategies undertaken by these companies to strengthen their market presence. Also, there are many companies that are upgrading their product portfolios in order to meet the current demand.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase Incidences of Chronic Diseases, Road Accidents, and Trauma Injuries
4.2.2 Technological Advancements in 3D Tissue Engineering
4.2.3 Increase in Funding and Research for Tissue Regeneration
4.3 Market Restraints
4.3.1 High Cost of Treatments Related to Tissue Engineering
4.3.2 Lack of Awareness Regarding Tissue Engineering
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Material
5.1.1 Synthetic Materials
5.1.2 Biologically Derived Materials
5.1.3 Others
5.2 By Application
5.2.1 Orthopedics
5.2.2 Musculoskeletal & Spine
5.2.3 Neurology
5.2.4 Cardiology & Vascular
5.2.5 Skin & Integumentary
5.2.6 Others
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 AbbVie Inc. (Allergan)
6.1.2 Integra Lifesciences
6.1.3 Becton, Dickinson and Company (C. R. Bard)
6.1.4 Zimmer Biomet
6.1.5 Organogenesis
6.1.6 Osiris Therapeutics
6.1.7 Biotime Inc.
6.1.8 B. Braun Melsungen AG
6.1.9 Bio Tissue Technologies

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc. (Allergan)
  • Integra Lifesciences
  • Becton, Dickinson and Company (C. R. Bard)
  • Zimmer Biomet
  • Organogenesis
  • Osiris Therapeutics
  • Biotime Inc.
  • B. Braun Melsungen AG
  • Bio Tissue Technologies